Company intelligence / Profile preview

BioLight

Guangzhou, Guangdong, Chinabio-light.co.il ↗

Ownership: Private
Development stage: Commercial

Overview

BioLight/BIOLIGHT develops and markets a broad range of medical devices including patient monitors, hemodialysis equipment, digital health solutions for homecare, as well as advanced optical imaging systems for life science research and diagnostics. The company has been publicly traded since 2011 on the Shenzhen Stock Exchange. It maintains strong R&D collaborations with leading Chinese universities and holds multiple patents in its field.

Industry: Physiological Monitoring

Drug pipeline

3 assets

IOPtiMate

Commercial

Indications: Glaucoma

2 more assets in the full pipeline.

Request access →

Partnerships

Sun Yat-sen UniversitySouth China University of TechnologyManufacturing Engineering Research Institute of Huazhong University of Science and Technology of DongguanSunTech Medical

Beyond the preview

Go deeper on BioLight.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioLight.

Explore the full profile